184 related articles for article (PubMed ID: 19188426)
1. Specific local cardiovascular changes of Nepsilon-(carboxymethyl)lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes-induced congenital heart defects.
Roest PA; Molin DG; Schalkwijk CG; van Iperen L; Wentzel P; Eriksson UJ; Gittenberger-de Groot AC
Diabetes; 2009 May; 58(5):1222-8. PubMed ID: 19188426
[TBL] [Abstract][Full Text] [Related]
2. The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function.
Zhu J; Yang K; Jing Y; Du R; Zhu Z; Lu L; Zhang R
Cardiovasc Diabetol; 2012 Aug; 11():90. PubMed ID: 22853433
[TBL] [Abstract][Full Text] [Related]
3. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas.
Murata T; Nagai R; Ishibashi T; Inomuta H; Ikeda K; Horiuchi S
Diabetologia; 1997 Jul; 40(7):764-9. PubMed ID: 9243096
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
[TBL] [Abstract][Full Text] [Related]
5. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
Hammes HP; Brownlee M; Lin J; Schleicher E; Bretzel RG
Diabetologia; 1999 May; 42(5):603-7. PubMed ID: 10333054
[TBL] [Abstract][Full Text] [Related]
6. Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody.
Schalkwijk CG; Baidoshvili A; Stehouwer CD; van Hinsbergh VW; Niessen HW
Biochim Biophys Acta; 2004 Mar; 1636(2-3):82-9. PubMed ID: 15164755
[TBL] [Abstract][Full Text] [Related]
7. Shixiang Plaster, a Traditional Chinese Medicine, Promotes Healing in a Rat Model of Diabetic Ulcer Through the receptor for Advanced Glycation End Products (RAGE)/Nuclear Factor kappa B (NF-κB) and Vascular Endothelial Growth Factor (VEGF)/Vascular Cell Adhesion Molecule-1 (VCAM-1)/Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathways.
Fei J; Ling YM; Zeng MJ; Zhang KW
Med Sci Monit; 2019 Dec; 25():9446-9457. PubMed ID: 31825949
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes mellitus induces congenital heart defects in murine embryos by increasing oxidative stress, endoplasmic reticulum stress, and apoptosis.
Wu Y; Reece EA; Zhong J; Dong D; Shen WB; Harman CR; Yang P
Am J Obstet Gynecol; 2016 Sep; 215(3):366.e1-366.e10. PubMed ID: 27038779
[TBL] [Abstract][Full Text] [Related]
9. MitoTempo protects against nε-carboxymethyl lysine-induced mitochondrial dyshomeostasis and neuronal cells injury.
Carvalho C; Moreira PI
Free Radic Biol Med; 2024 Aug; 220():192-206. PubMed ID: 38734265
[TBL] [Abstract][Full Text] [Related]
10. Mechanical ventilation during experimental sepsis increases deposition of advanced glycation end products and myocardial inflammation.
Kneyber MC; Gazendam RP; Niessen HW; Kuiper JW; Dos Santos CC; Slutsky AS; Plötz FB
Crit Care; 2009; 13(3):R87. PubMed ID: 19508707
[TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility of HIF-1α heterozygous-null mice to cardiovascular malformations associated with maternal diabetes.
Bohuslavova R; Skvorova L; Sedmera D; Semenza GL; Pavlinkova G
J Mol Cell Cardiol; 2013 Jul; 60():129-41. PubMed ID: 23619295
[TBL] [Abstract][Full Text] [Related]
12. Overproduction of N(epsilon)-(carboxymethyl)lysine-induced neovascularization in cultured choroidal explant of streptozotocin-diabetic rat.
Kobayashi S; Suzuki M; Tsuneki H; Nagai R; Horiuchi S; Hagino N
Biol Pharm Bull; 2004 Oct; 27(10):1565-71. PubMed ID: 15467196
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
14. Receptor for advanced glycation end products (RAGE) knockout reduces fetal dysmorphogenesis in murine diabetic pregnancy.
Ejdesjö A; Brings S; Fleming T; Fred RG; Nawroth PP; Eriksson UJ
Reprod Toxicol; 2016 Jul; 62():62-70. PubMed ID: 27109771
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages.
Urata Y; Yamaguchi M; Higashiyama Y; Ihara Y; Goto S; Kuwano M; Horiuchi S; Sumikawa K; Kondo T
Free Radic Biol Med; 2002 Apr; 32(8):688-701. PubMed ID: 11937295
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of receptor for advanced glycation end products, VEGF and CML in plasma, follicular fluid, and peritoneal fluid in women with and without endometriosis.
Fujii EY; Nakayama M; Nakagawa A
Reprod Sci; 2008 Dec; 15(10):1066-74. PubMed ID: 19088375
[TBL] [Abstract][Full Text] [Related]
17. Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus.
van Deutekom AW; Niessen HW; Schalkwijk CG; Heine RJ; Simsek S
Eur J Endocrinol; 2008 May; 158(5):655-60. PubMed ID: 18426823
[TBL] [Abstract][Full Text] [Related]
18. Overproduction of N(epsilon)-(carboxymethyl)lysine-induced neovascularization in cultured choroidal explant of aged rat.
Kobayashi S; Nomura M; Nishioka T; Kikuchi M; Ishihara A; Nagai R; Hagino N
Biol Pharm Bull; 2007 Jan; 30(1):133-8. PubMed ID: 17202673
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry of advanced glycation end product N
Nogami M; Hoshi T; Toukairin Y; Arai T; Nishio T
BMC Res Notes; 2020 May; 13(1):239. PubMed ID: 32398121
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
